24VA021; VATCH Trametinib for Ras/MAPK Pathway VAs

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
24VA021; VATCH Trametinib for Ras/MAPK Pathway VAs	Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiovascular disorder, vascular malformation	Active, not recruiting	Phase 2	2026-04-24		NCT07549646

27 results · Page 1 of 2

Swipe the table sideways for more columns.

Organizations	Linked trials
Arkansas Children's Hospital Research Institute	37
Baylor College of Medicine	267
Boston Children's Hospital	238
CaNVAS (Consortium of Investigators of Vascular Anomalies)	2
Children's Healthcare of Atlanta	24
Children's Hospital Colorado	46
Children's Hospital Medical Center, Cincinnati	229
Children's Hospital of Los Angeles (CHLA)	3
Children's Hospital of Orange County	22
Children's Hospital of Philadelphia	215
Children's Hospital of Pittsburg	2
Children's Wisconsin - Milwaukee	2
Columbia University	375
Dell Children's Medical Center of Central Texas	6
Helen DeVos Children's Hospital	5
Lucile Packard Children's Hospital Stanford	3
Nationwide Children's Hospital	97
Nemours Children's Health	2
Novartis	114
NYU Langone Health	359
Oregon Health and Science University	244
Riley Children's Health	2
Seattle Children's Hospital	97
University of California, San Francisco	637
University of North Carolina	30

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Children's Hospital of Philadelphia	Philadelphia	United States	434

Clinical trials